PKU GOLIKE

Founded: 2022 • Age: 4 yrs Acquired By Eton Pharmaceuticals
Company offers pre measured packets and bars containing amino acids for the dietary management of phenylketonuria

About PKU GOLIKE

PKU GOLIKE is a Healthcare company founded in 2022, and was acquired by Eton Pharmaceuticals in March 2024. Company offers pre measured packets and bars containing amino acids for the dietary management of phenylketonuria. Its chief executive, as recorded, is Michelle Lock. Its focus areas include Pharmaceutical Product Websites. Its legal entity is Eton Pharmaceuticals.

Company details

PKU GOLIKE was established in 2022 as a product line in the medical nutrition sector, focused on dietary support for phenylketonuria. Coated granule formulations of 19 essential amino acids are delivered through pre-measured packets and bars, designed for gradual release and absorption. Operations center on product availability in the United States, introduced in October 2022, with Michelle Lock serving as CEO.

Key Metrics

Investors in PKU GOLIKE

PKU GOLIKE has secured backing from 1 investor. Prominent investors backing the company include Eton Pharmaceuticals.

All
InvestorDescriptionFounded YearDomainLocation
Sterile injectables are developed and commercialized by Eton Pharmaceuticals.
2013etonpharma.comBarrington, United States
Premium access

Investor details for PKU GOLIKE

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of PKU GOLIKE

1 people are tracked at PKU GOLIKE (1 in leadership).

NameRoleGroup
Michelle Lock
CEOLeadership
Premium access

Complete people profiles for PKU GOLIKE

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of PKU GOLIKE

2 dated milestones of PKU GOLIKE across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded PKU GOLIKE is founded.
  2. Exit Acquired by Eton Pharmaceuticals.

Web traffic of PKU GOLIKE

The website of PKU GOLIKE (pkugolike.com) receives about 2K visits a month.

  • Monthly visits
    2K

    ▼ 5% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about PKU GOLIKE

PKU GOLIKE was founded in 2022.

Michelle Lock is the CEO of PKU GOLIKE, as recorded in our data.

PKU GOLIKE was established in 2022 as a product line in the medical nutrition sector, focused on dietary support for phenylketonuria. Coated granule formulations of 19 essential amino acids are delivered through pre-measured packets and bars, designed for gradual release and absorption. Operations center on product availability in the United States, introduced in October 2022, with Michelle Lock serving as CEO.

PKU GOLIKE has 1 investor. Key investors include Eton Pharmaceuticals.

PKU GOLIKE operates through Eton Pharmaceuticals.

Yes. PKU GOLIKE was acquired by Eton Pharmaceuticals in March 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available